Javascript must be enabled to continue!
Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice
View through CrossRef
The expression of the tissue kallikrein gene is tissue-specific and exhibits a complex pattern of transcriptional and post-translational regulation. Information concerning the mechanism of its tissue-specific expression has been limited owing to the lack of suitable cell lines for the expression study. We approached this problem by introducing human tissue kallikrein gene constructs into mouse embryos, creating transgenic lines carrying its coding sequence with varying lengths of the promoter region. One construct (PHK) contained 801 bp in the 5′-flanking region and two deletion constructs contained either 302 bp (D300) or 202 bp (D200) of the promoter region. The expression of human tissue kallikrein in these transgenic mice was monitored by Northern blot, reverse transcriptase–PCR followed by Southern blot, and radioimmunoassay. In all three lines, human tissue kallikrein was expressed predominantly in the pancreas and at lower levels in other tissues, including salivary gland, kidney and spleen. This pattern was similar to that of tissue kallikrein expression in human tissues. The D300 line has higher levels of transgene expression than the D200 and PHK lines. The results indicate that the 202 bp segment immediately upstream of the translation starting site is sufficient to direct a tissue-specific expression pattern of the human tissue kallikrein gene, and that regulatory elements might exist between -801 and -202.
Title: Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice
Description:
The expression of the tissue kallikrein gene is tissue-specific and exhibits a complex pattern of transcriptional and post-translational regulation.
Information concerning the mechanism of its tissue-specific expression has been limited owing to the lack of suitable cell lines for the expression study.
We approached this problem by introducing human tissue kallikrein gene constructs into mouse embryos, creating transgenic lines carrying its coding sequence with varying lengths of the promoter region.
One construct (PHK) contained 801 bp in the 5′-flanking region and two deletion constructs contained either 302 bp (D300) or 202 bp (D200) of the promoter region.
The expression of human tissue kallikrein in these transgenic mice was monitored by Northern blot, reverse transcriptase–PCR followed by Southern blot, and radioimmunoassay.
In all three lines, human tissue kallikrein was expressed predominantly in the pancreas and at lower levels in other tissues, including salivary gland, kidney and spleen.
This pattern was similar to that of tissue kallikrein expression in human tissues.
The D300 line has higher levels of transgene expression than the D200 and PHK lines.
The results indicate that the 202 bp segment immediately upstream of the translation starting site is sufficient to direct a tissue-specific expression pattern of the human tissue kallikrein gene, and that regulatory elements might exist between -801 and -202.
Related Results
Human tissue kallikrein induces hypotension in transgenic mice.
Human tissue kallikrein induces hypotension in transgenic mice.
We investigated the role of the kallikrein-kinin system in blood pressure control by developing transgenic mice overexpressing human tissue kallikrein. Two lines of transgenic mice...
e0061 The modulation of dilated cardiomyopathy by Hepc1 in cTnTR141W transgenic mice
e0061 The modulation of dilated cardiomyopathy by Hepc1 in cTnTR141W transgenic mice
Objective
Iron regulatory hormone hepcidin is possible to be possibly involved in the physiological function of heart and pathogenesis of heart disease. The curre...
e0048 CYP2E1 increases oxidative stress and induces apoptosis of cardio myocytes in transgenic mice
e0048 CYP2E1 increases oxidative stress and induces apoptosis of cardio myocytes in transgenic mice
Objective
Cytochrome P450 2E1 (CYP2E1) is an effective generator of reactive oxygen species, such as the superoxide anion radical and hydrogen peroxide. The expre...
Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats
Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats
AbstractWe recently found that transgenic mice expressing human tissue kallikrein develop sustained hypotension. The result suggests that a continuous supply of human tissue kallik...
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats
In DOCA-salt hypertension, renal kallikrein levels are increased and may play a protective role in renal injury. We investigated the effect of enhanced kallikrein levels on kidney ...
Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis
Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis
Kallikrein/kinin has been shown to protect against ischemia/reperfusion-induced myocardial infarction and apoptosis. In the present study, we examined the potential neuroprotective...
Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation
Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation
Tissue kallikrein exerts various biological functions through kinin formation with subsequent kinin B2 receptor activation. Recent studies showed that tissue kallikrein directly ac...
Downregulation of the CYP2E1 ameliorates oxidative stress and apoptosis
Downregulation of the CYP2E1 ameliorates oxidative stress and apoptosis
Objective
Cytochrome P450 2E1 (CYP2E1) is an effective generator of reactive oxygen species, and it is known to be regulated in the course of progression of myoca...

